HCP

Further Information

SmPC

Dymista^®^ "can be considered the drug of choice"^1^ for moderate to severe Allergic Rhinitis

Dymista is indicated for the relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.^2^

Adverse events should be reported to Meda: pv@meda.ie

  1. Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D, Munzel U, Bousquet J. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
  2. Dymista Summary of Product Characteristics.